Sickle Cell Disease: Symptoms, Diagnosis and What Causes It

What if something as small as a change in the shape of a blood cell could affect an entire life?

Sickle cell disease is one of the most common inherited blood disorders in the world, yet it remains widely misunderstood. Affecting nearly 7.7 million people globally and accounting for over 500,000 new births every year, this condition poses a significant public health challenge, especially in regions like India, where thousands of children are born with it annually.

It is often referred to as sickle cell anemia in its most severe form alters the structure of red blood cells, turning them from smooth, round carriers of oxygen into rigid, sickle-shaped cells. These distorted cells can block blood flow, trigger severe pain episodes, and lead to serious complications if not managed early and effectively.

With modern advances in diagnosis, newborn screening, and disease-modifying therapies, outcomes today are far better than they were just a decade ago. In this comprehensive guide, we break down everything you need to know, from types of sickle cell disease and sickle cell trait to diagnosis, treatment, and prevention of sickle cell anemia.

What is sickle cell anemia (and what causes it)?

Sickle cell anemia is caused by a single point mutation in the HBB gene that produces an abnormal form of haemoglobin called hemoglobin S. When red blood cells contain a high proportion of haemoglobin S, they can deform into a rigid, sickle shape under low-oxygen conditions.

These misshapen cells are less flexible, break down earlier, and can obstruct small blood vessels, leading to pain and organ damage. The condition is inherited in an autosomal codominant pattern: two copies of the mutated gene typically cause disease, while one copy produces the sickle cell trait (SCT).

Types of sickle cell disease

There are several genotypes (types) of SCD depending on which hemoglobin genes are inherited. Common types include:

• Hemoglobin SS (HbSS): often called sickle cell anemia; generally, the most severe form.
• Hemoglobin SC (HbSC): usually milder but can still cause complications.
• HbS/β-thalassemia: combination of sickle gene plus beta-thalassemia mutation; severity varies.

(When someone carries just one S gene, they have sickle cell trait and are usually asymptomatic, though they can pass the gene to children.)

Common symptoms (sickle cell anemia symptoms)

Symptoms vary by age and genotype but commonly include:

• Recurrent pain crises (acute Vaso-occlusive episodes) in bones, chest, or abdomen.
• Chronic anemia: fatigue, pallor, poor growth in children.
• Frequent infections due to functional asplenia (reduced spleen function).
• Acute chest syndrome, stroke, leg ulcers, and organ dysfunction in severe cases.
• Early childhood presentations often include dactylitis (painful swelling of hands and feet) and failure to thrive.

How is SCD diagnosed?

• Newborn screening: Most programmes use high-performance liquid chromatography (HPLC) or hemoglobin electrophoresis to detect abnormal hemoglobin types at birth; early detection saves lives.
• Confirmatory testing: DNA analysis can clarify ambiguous cases or identify specific genotypes.
• Routine monitoring: It includes full blood counts, reticulocyte counts, organ imaging (e.g., transcranial Doppler for stroke risk), and infection screening, which is part of ongoing care.

Sickle cell anemia treatment: current standards

Management is multidisciplinary, aimed at preventing complications and improving quality of life:

• Supportive care: prompt pain control, hydration, oxygen, and treatment of triggers (infection, dehydration).
• Infection prevention: prophylactic penicillin for infants and up-to-date vaccinations dramatically reduce early childhood mortality.
• Hydroxyurea: a disease-modifying medication that increases fetal hemoglobin (HbF), reduces pain crises, hospitalizations, and acute chest syndrome; long-term data support safety and benefits for many patients.
• Blood transfusions: chronic transfusion regimes are used for stroke prevention and severe complications; iron overload is a long-term concern requiring chelation.
• Hematopoietic stem cell transplant (HSCT): the only widely established curative therapy today when a suitable donor is available; best outcomes occur with matched sibling donors.

Emerging and advanced therapies

Gene therapies and gene editing: clinical trials using CRISPR and other gene-editing techniques to reactivate fetal hemoglobin or correct the sickle mutation have produced promising results; some patients shown marked improvement and reduced crises, but long-term safety and access remain under study.

Prevention of sickle cell anemia (and genetic counselling)

Prevention centres on screening and counselling:

• Premarital and antenatal screening identify carriers (e.g., sickle cell trait), so couples understand reproductive risks.
• Newborn screening ensures babies at risk to receive early prophylaxis and follow-up.
• Public health campaigns in high-prevalence regions (screening, education, and linkage to care) are proven tools to reduce disease burden. Recent state-driven screening campaigns in India have uncovered thousands of carriers and cases, underscoring the importance of targeted screening.

Conclusion

Sickle cell disease is a lifelong, genetic blood disorder with a wide clinical spectrum from mild forms to life-threatening complications. Advances such as hydroxyurea, improved supportive care, wider newborn screening, and cutting-edge curative approaches (HSCT and gene editing) are changing outcomes for many patients. If you or a family member has sickle cell, early diagnosis, regular follow-up, and a multidisciplinary team are essential for the best possible quality of life.

For expert care and a coordinated approach to diagnosis, management and advanced therapies, consider consulting your local specialists. Sparsh Hospital provides comprehensive haematology services, multidisciplinary care , and genetic counselling, positioning it as a strong choice for families seeking the Best Haematology Hospital in Bangalore and access to experienced Haematologists in Bangalore.

Frequently Asked Questions

1. What is sickle cell anemia?

Sickle cell anemia is an inherited blood disorder where red blood cells become rigid and sickle-shaped, causing anemia, pain episodes, infections, and potential organ damage.

2. What are the common sickle cell anemia symptoms?

Common sickle cell anemia symptoms include severe pain crises, fatigue, pale skin, swelling of hands and feet, frequent infections, delayed growth, and shortness of breath.

3. What causes sickle cell disease?

A mutation in the HBB gene causes sickle cell disease. A child develops the condition when both parents pass on the defective gene.

4. Can sickle cell anemia be cured?

A stem cell or bone marrow transplant can potentially cure sickle cell anemia. However, it requires a suitable donor and is not suitable for all patients.

5. What is sickle cell trait?

Sickle cell trait occurs when a person inherits one sickle gene and one normal gene. They usually have no symptoms but can pass the gene to their children.